KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Tax Provisions: 2009-2025

Historic Tax Provisions for Rigel Pharmaceuticals (RIGL) over the last 2 years, with Sep 2025 value amounting to -$280,000.

  • Rigel Pharmaceuticals' Tax Provisions was N/A to -$280,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $900,000 for FY2024, which is N/A change from last year.
  • Rigel Pharmaceuticals' Tax Provisions amounted to -$280,000 in Q3 2025, which was down 175.88% from $369,000 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Tax Provisions registered a high of $1.8 million during Q1 2021, and its lowest value of -$1.0 million during Q2 2021.
  • Its 2-year average for Tax Provisions is $272,250, with a median of $234,500 in 2025.